Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Daniel E. Stange

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4246-2230; OpenAlex author ID A5004040583. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
53
Papers, trials and grants by year

2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 3 papers

Papers 9

  1. A biomaterial-based platform of pancreatic cancer reveals kallikrein-related peptidase 6 (KLK6) as a mediator of neutrophil recruitment and immunosuppression. Co-author DOI 10.1016/j.biomaterials.2025.123456↗
  2. A pancreatic cancer organoid-macrophage co-culture using starPEG-heparin hydrogel deciphers tumor-immune cell interactions. Co-author DOI 10.1038/s41698-026-01678-6↗
  3. Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancer. Co-author DOI 10.1172/jci.insight.194290↗
  4. Molecular Spectroscopy for the Biochemical Composition Analysis of Patient-Derived Pancreatic Cancer Organoids. Co-author DOI 10.1002/cam4.70457↗
  5. A Tumor Microenvironment Model of Pancreatic Cancer to Elucidate Responses toward Immunotherapy. Co-author DOI 10.1002/adhm.202201907↗
  6. Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment. Last author DOI 10.1002/path.5906↗
  7. Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. Co-author DOI 10.1172/jci.insight.137809↗
  8. CFTR Expression Analysis for Subtyping of Human Pancreatic Cancer Organoids. Co-author DOI 10.1155/2019/1024614↗
  9. Erratum to "CFTR Expression Analysis for Subtyping of Human Pancreatic Cancer Organoids". Co-author DOI 10.1155/2019/9209764↗

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Franziska Baenke · 5 shared papers, 2022–2026 · strength 1.03
  2. Jürgen Weitz · 6 shared papers, 2019–2026 · strength 0.96
  3. Daniela Loessner · 3 shared papers, 2023–2026 · strength 0.64
  4. Verena Kast · 3 shared papers, 2023–2026 · strength 0.64
  5. Adrian M. Seifert · 2 shared papers, 2026 · strength 0.45
  6. Lena Seifert · 2 shared papers, 2026 · strength 0.45
  7. Alexander Hennig · 4 shared papers, 2019–2022 · strength 0.35
  8. Thilo Welsch · 4 shared papers, 2019–2022 · strength 0.35
  9. Marius Distler · 3 shared papers, 2019–2022 · strength 0.28
  10. Jens Pietzsch · 1 shared paper, 2026 · strength 0.25
  11. Michael Seifert · 1 shared paper, 2026 · strength 0.25
  12. David Digomann · 1 shared paper, 2026 · strength 0.24
  13. Max Heiduk · 1 shared paper, 2026 · strength 0.24
  14. Loreen Natusch · 1 shared paper, 2026 · strength 0.24
  15. Sarah Cronjaeger · 1 shared paper, 2026 · strength 0.24
  16. Diane M. Simeone · 1 shared paper, 2026 · strength 0.24
  17. Christian Teske · 1 shared paper, 2024 · strength 0.23
  18. Gerald R. Steiner · 1 shared paper, 2024 · strength 0.23
  19. Julius Thyen · 1 shared paper, 2026 · strength 0.21
  20. Mathieu Pecqueux · 1 shared paper, 2026 · strength 0.21
  21. Marc Schmitz · 1 shared paper, 2026 · strength 0.21
  22. Kim C. Honselmann · 1 shared paper, 2023 · strength 0.18
  23. Maximilian Reichert · 2 shared papers, 2020–2022 · strength 0.18
  24. Kristin Werner · 2 shared papers, 2019 · strength 0.17
  25. Christoph Kahlert · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.